Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -951.92% is 822% below its 5-year average of -103.21%, near the low end of its 5-year range (-951.92%–-12.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 185.42% below its 12-month average of -333.51%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -951.92%.
RETURN ON EQUITY (ROE)
-951.92%
RETURN ON EQUITY (ROE) AVG TTM
-333.51%
RETURN ON EQUITY (ROE) AVG 3Y
-135.35%
RETURN ON EQUITY (ROE) AVG 5Y
-103.21%
RETURN ON EQUITY (ROE) AVG 10Y
-81.86%
RETURN ON EQUITY (ROE) AVG 15Y
-81.56%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-185.42%
CURRENT VS 3Y AVG
-603.31%
CURRENT VS 5Y AVG
-822.30%
CURRENT VS 10Y AVG
-1062.90%
CURRENT VS 15Y AVG
-1067.12%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-2427.66%
vs the sector median at left
Cocrystal Pharma, Inc.
Market Cap
$15.30M
Return on Equity (ROE)
-951.92%
TTM Avg
-333.51%
3Y Avg
-135.35%
5Y Avg
-103.21%
Market Cap
$15.20M
Return on Equity (ROE)
-42.72%
TTM Avg
-65.53%
3Y Avg
-58.02%
5Y Avg
-43.63%
Market Cap
$15.20M
Return on Equity (ROE)
N/A
TTM Avg
54.00%
3Y Avg
301.36%
5Y Avg
162.15%
Market Cap
$15.91M
Return on Equity (ROE)
-348.81%
TTM Avg
-160.92%
3Y Avg
-184.71%
5Y Avg
-151.29%
Market Cap
$16.22M
Return on Equity (ROE)
-271.81%
TTM Avg
-934.34%
3Y Avg
-347.56%
5Y Avg
-265.02%
Market Cap
$14.28M
Return on Equity (ROE)
-69.47%
TTM Avg
-55.64%
3Y Avg
-44.95%
5Y Avg
-41.56%
Market Cap
$16.54M
Return on Equity (ROE)
N/A
TTM Avg
-416.37%
3Y Avg
-259.03%
5Y Avg
-190.00%
Market Cap
$16.58M
Return on Equity (ROE)
-101.76%
TTM Avg
-188.04%
3Y Avg
-167.76%
5Y Avg
-134.95%
Market Cap
$13.62M
Return on Equity (ROE)
-101.66%
TTM Avg
-140.38%
3Y Avg
-131.64%
5Y Avg
-101.94%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | $15.30M | -951.92% | -333.51% | -135.35% | -103.21% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.20M | -42.72% | -65.53% | -58.02% | -43.63% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.20M | N/A | 54.00% | 301.36% | 162.15% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -348.81% | -160.92% | -184.71% | -151.29% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -271.81% | -934.34% | -347.56% | -265.02% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -69.47% | -55.64% | -44.95% | -41.56% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | N/A | -416.37% | -259.03% | -190.00% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -101.76% | -188.04% | -167.76% | -134.95% |
| IN8bio, Inc. (INAB)vs › | $13.62M | -101.66% | -140.38% | -131.64% | -101.94% |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | -186.95% | 1198.98% | 241.18% | 112.17% |
ROE
-951.9%
ROA
-213.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -951.92% |
| 2026-03-31 | -214.50% |
| 2025-12-31 | -139.49% |
| 2025-09-30 | -126.11% |
| 2025-06-30 | -235.53% |
| 2025-03-31 | -216.99% |
| 2024-12-31 | -183.81% |
| 2024-09-30 | -147.23% |
| 2024-06-30 | -103.09% |
| 2024-03-31 | -74.17% |
| 2023-12-31 | -68.16% |
| 2023-09-30 | -58.72% |
| 2023-06-30 | -56.39% |
| 2023-03-31 | -114.85% |
| 2022-12-31 | -98.16% |
| 2022-09-30 | -86.59% |
| 2022-06-30 | -73.42% |
| 2022-03-31 | -21.28% |
| 2021-12-31 | -18.29% |
| 2021-09-30 | -14.80% |
| 2021-06-30 | -12.65% |
| 2021-03-31 | -19.97% |
| 2020-12-31 | -18.38% |
| 2020-09-30 | -111.60% |
| 2020-06-30 | -148.72% |
| 2020-03-31 | -131.41% |
| 2019-12-31 | -187.37% |
| 2019-09-30 | -63.06% |
| 2019-06-30 | -61.72% |
| 2019-03-31 | -60.32% |
| 2018-12-31 | -73.33% |
| 2018-09-30 | 0.39% |
| 2018-06-30 | 0.04% |
| 2018-03-31 | 0.37% |
| 2017-12-31 | -0.58% |
| 2017-09-30 | -71.57% |
| 2017-06-30 | -69.76% |
| 2017-03-31 | -73.42% |
| 2016-12-31 | -73.18% |
| 2016-09-30 | -23.58% |
| 2016-06-30 | -22.89% |
| 2016-03-31 | -22.20% |
| 2015-12-31 | -29.91% |
| 2015-09-30 | -10.97% |
| 2015-06-30 | -12.02% |
| 2015-03-31 | -8.62% |
| 2014-12-31 | -1.47% |
| 2014-09-30 | -258.49% |
| 2014-06-30 | -215.36% |
| 2011-06-30 | -163.16% |
| 2011-03-31 | -812.04% |
| 2010-12-31 | -463.24% |
| 2010-09-30 | -270.29% |
| 2010-06-30 | -117.92% |
| 2010-03-31 | -50.68% |
| 2009-12-31 | -72.40% |
| 2009-09-30 | -58.28% |
| 2009-06-30 | -57.36% |
| 2009-03-31 | -61.39% |
| 2008-12-31 | -54.72% |
| 2008-09-30 | -79.14% |
| 2008-06-30 | -78.81% |
